Corpus Intelligence IC Memo — VIRGINIA BEACH PSYCHIATRIC CENTER 2026-04-26 17:26 UTC
IC Memo — VIRGINIA BEACH PSYCHIATRIC CENTER
Investment Committee Memorandum | VA | 100 beds | Grade C | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VIRGINIA BEACH PSYCHIATRIC CENTER

CCN 494025 | nan, VA | 100 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VIRGINIA BEACH PSYCHIATRIC CENTER is a 100-bed community hospital in nan, VA with $19.0M in net patient revenue and a -1.2% operating margin. The hospital serves a payer mix of 8.0% Medicare, 0.0% Medicaid, and 92.0% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.2% to 6.2% (+736bps).

Net Revenue HCRIS$19.0M
Current EBITDA COMPUTED$-219K
Operating Margin COMPUTED-1.2%
Occupancy HCRIS66.6%
Revenue / Bed COMPUTED$190K
Net-to-Gross HCRIS37.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
53
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -1.2% places it below the state median. Among 53 size-comparable peers (50-200 beds), the median margin is 7.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VIRGINIA BEACH PSYCHIATRIC CEN (Target)VA100$19.0M-1.2%
INOVA LOUDOUN HOSPITAL CENTERVA189$510.3M22.9%
INOVA FAIR OAKS HOSPITALVA174$382.5M28.5%
SENTARA MARTHA JEFFERSON HOSPIVA150$362.0M-6.4%
SENTARA PRINCESS ANNE HOSPITALVA174$361.5M10.3%
MARYVIEW HOSPITALVA160$348.0M-2.5%
ST. FRANCIS MEDICAL CENTERVA128$339.6M8.6%
SENTARA OBICI HOSPITALVA186$329.1M15.1%
SENTARA CAREPLEX HOSPITALVA169$302.5M9.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$400K+210bp18mo
Cost to Collect4.5%2.5%$381K+200bp12mo
Denial Rate Reduction12.0%6.5%$377K+198bp12mo
A/R Days Reduction5200.0%3800.0%$232K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$400K
Cost to Collect
$381K
Denial Rate Reduction
$377K
A/R Days Reduction
$232K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-219K
+ RCM Uplift+$1.4M
Pro Forma EBITDA$1.2M
Current Margin-1.2%
Pro Forma Margin6.2%
WC Released (1x)$730K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-337K$12.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-337K$13.7M0.00x-100.0%
Bull Case9.0x11.0x$-304K$18.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-304K$19.8M0.00x-100.0%
Bear Case11.0x10.0x$-371K$5.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-371K$6.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 50-200 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-6.4% / P50=7.3% / P75=15.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.